期刊文献+

hSulf-1基因腺病毒表达载体的构建及其对血管内皮细胞增殖、迁移能力的影响 被引量:2

Construction of adenovirus vector carrying hSulf-1 gene and its effects on proliferation and migration of human endothelial cells
下载PDF
导出
摘要 目的构建携带人硫酸酯酶1基因(hSulf-1)的腺病毒载体,研究其对于人脐静脉内皮细胞ECV-304增殖、迁移能力的影响。方法通过基因操作技术将hSulf-1基因插入到腺病毒基因组中,构建重组腺病毒Ad5-hSulf1;应用蛋白质免疫印迹法检测hSulf-1蛋白在ECV-304细胞中的表达及细胞内磷酸化Akt、ERK的表达变化;MTT实验检测hSulf-1过表达对于ECV-304细胞增殖的影响;采用划痕实验研究hSulf-1过表达对于ECV-304细胞迁移的影响。结果成功构建携带目的基因hSulf-1的腺病毒载体;免疫印迹结果表明hSulf1基因过表达会下调ECV-304细胞Akt和ERK信号分子的磷酸化水平;细胞增殖实验结果表明hSulf1基因过表达抑制了ECV-304细胞增殖,感染复数为50、100时细胞存活率下降至(68.49±0.05)%以及(67.78±0.06)%(P<0.05);划痕实验结果表明hSulf1基因过表达能够抑制细胞的迁移,相比于对照组细胞迁移能力减弱(P<0.01)。结论重组腺病毒Ad5-hSulf1介导的hSulf-1基因在ECV-304细胞中的过表达明显抑制细胞增殖及迁移,为hSulf-1用于肿瘤及血管生长相关疾病的基因治疗奠定了基础。 Objective To construct a recombinant adenovirus vector carrying hSulf-1 gene and to investigate its effect on the proliferation and migration of human umbilical vein endothelial cells.Methods The hSulf-1 protein was inserted into adenovirus genome to generate recombinant adenovirus Ad5-hSulf1,and then the virus was used to infect ECV-304 cell line.The expression of hSulf-1 protein was detected by Western blotting analysis,the cell viability was examined by MTT assay,and the cell migration ability was evaluated by wound-healing assay in ECV-304 cells.Results The recombinant adenovirus Ad5-hSulf1 was successfully constructed.Western blotting analysis showed that over-expression of hSulf1 down-regulated the phosphorylation levels of Akt and ERK in ECV-304 cells.MTT assay showed that over-expression of hSulf1 inhibited the proliferation of ECV-304 cells,with the cell survival rate decreased to(68.49±0.05)% at MOI of 50 pfu/ml and(67.78±0.06)% at MOI of 100 pfu/ml(P0.05).Wound-healing assay showed that over-expression of hSulf1 significantly inhibited the migration of ECV-304 cells compared with the control group(P0.01).Conclusion The recombinant adenovirus Ad5-hSulf1-mediated hSulf-1 over-expression can markedly inhibit the proliferation and migration of ECV-304 cells,laying a foundation for hSulf-1 related gene therapy of tumor and angiogenesis-associated diseases.
出处 《第二军医大学学报》 CAS CSCD 北大核心 2012年第3期247-251,共5页 Academic Journal of Second Military Medical University
基金 国家科技重大专项(2009ZX09102-235) 国家自然科学基金(81172019 81172303)~~
关键词 腺病毒 hSulf-1基因 血管 内皮细胞 细胞增殖 细胞运动 adenovirus hSulf-1 gene blood vessels endothelial cells cell proliferation cell movement
  • 相关文献

参考文献16

  • 1Ji W,Yang J,Wang D,Cao L,Tan W,Qian H,et al.hSulf-1 geneexhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers[J].PLoS One,2011,6:e23274.
  • 2Narita K,Chien J,Mullany S A,Staub J,Qian X,Lingle W L,et al.Loss of hSulf-1 expression enhances autocrine signaling mediatedby amphiregulin in breast cancer[J].J Biol Chem,2007,282:14413-14420.
  • 3Khurana A,Liu P,Mellone P,Lorenzon L,Vincenzi B,Datta K,etal.HSulf-1 modulates FGF2-and hypoxia-mediated migrationand invasion of breast cancer cells[J].Cancer Res,2011,71:2152-2161.
  • 4Lai J,Chien J,Staub J,Avula R,Greene E L,Matthews T A,et al.Loss of hSulf-1 up-regulates heparin-binding growth factor sig-naling in cancer[J].J Biol Chem,2003,278:23107-23117.
  • 5Potente M,Gerhardt H,Carmeliet P.Basic and therapeutic aspectsof angiogenesis[J].Cell,2011,146:873-887.
  • 6Escudier B,Albiges L.Vascular endothelial growth factor-targetedtherapy for the treatment of renal cell carcinoma[J].Drugs,2011,71:1179-1191.
  • 7LaBarre D D,Lowy R J.Improvements in methods for calculatingvirus titer estimates from TCID50 and plaque assays[J].J VirolMethods,2001,96:107-126.
  • 8Chen Z,Fan J Q,Li J,Li Q S,Yan Z,Jia X K,et al.Promoter hy-permethylation correlates with the hSulf-1 silencing in humanbreast and gastric cancer[J].Int J Cancer,2009,124:739-744.
  • 9Staub J,Chien J,Pan Y,Qian X,Narita K,Aletti G,et al.Epigenet-ic silencing of hSulf-1 in ovarian cancer:implications in che-moresistance[J].Oncogene,2007,26:4969-4978.
  • 10Raman K,Kuberan B.Chemical tumor biology of heparan sulfateproteoglycans[J].Curr Chem Biol,2010,4:20-31.

同被引文献25

  • 1Morimoto-Tomita M, Uchimura K, Werb Z, et al. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans [J]. J Bioi Chern, 2002, 277 (51 ) : 4917549185.
  • 2Frese MA, Milz F, Dick M, et al. Characterization of the human sulfatase Sulfl and its high affinity heparin/heparan sulfate interaction domain [J]. J Bioi Chern, 2009, 284 ( 41 ): 28033- 28044.
  • 3Yang JD, Sun Z, Hu C, et al. Sulfatase 1 and sulfatase 2 in hepatocellular carcinoma: associated signaling pathways, tumor phenotypes, and survival [J]. Genes Chromosomes Cancer, 2011, 50 (2): 122-135.
  • 4Lai J, Chien J, Staub J, et al. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer [J]. J Bioi Chern, 2003,278(25): 23107-23117.
  • 5Tutt A, Robson M, Garber JE, et al. Oral poly (ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: A proof-of-concept trial [J]. Lancet, 2010, 376(9737) : 235-244.
  • 6Dent RA, Lindeman GJ, Clemons M, et al. Phase I trial of the oral P ARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triplenegative breast cancer [J]. Breast Cancer Res, 2013, 15 ( 5 ) : 88-96.
  • 7Rajan A, Carter CA, Kelly RJ, et al. A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors [J]. Clin Cancer Res, 2012,18(8): 2344-2351.
  • 8Weidan Ji, Jiahe Yang, Duanming Wang, et al. hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers [J]. PLoS ONE, 2011, 6 ( 8 ) : e23274.
  • 9Narita K, Staub J, Chien J, et al. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo [J]. Cancer Res, 2006, 66 ( 12) : 6025.Q032.
  • 10Narita K, Chien J, Mullany SA, et al. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer [J]. J Bioi Chern, 2007, 282(19) : 14413-14420.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部